We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics and Nanoplastics in Aesthetic Medicine: An Update and Literature Review (2021–2025)
Original title: Microplastics and Nanoplastics in Aesthetic Medicine: An Update and Literature Review (2021–2025)
Summary
This review of 30 studies (2021–2025) finds that tiny plastic particles used in cosmetics and dermal fillers—especially the smallest ones, called nanoplastics—can actually penetrate your skin's outer barrier and trigger inflammation and irritation in skin cells. The good news: biodegradable alternatives already exist and work just as well, so the beauty industry has a real opportunity to phase out these plastics if regulators push for it. More research is still needed to understand long-term effects on the body.
Background: The integration of synthetic polymers into aesthetic medicine and personal care products has led to growing scrutiny regarding microplastics (MPs) and nanoplastics (NPs). While these materials enhance product performance, texture, and delivery, emerging evidence suggests potential adverse effects on cutaneous health and significant environmental persistence. This review provides a comprehensive update on the presence, penetration, and toxicological impact of MPs and NPs in aesthetic medicine. Methods: A systematic literature search was conducted using MEDLINE, PubMed, and Ovid databases for studies published between January 2021 and early 2025. Keywords included “microplastics,” “nanoplastics,” “cosmetics,” and “aesthetic medicine.” Thirty articles were selected and analyzed based on the Oxford Centre for Evidence-Based Medicine (CEBM) levels of evidence. Results: Recent data confirms that MPs and NPs are ubiquitous in cosmetic formulations, including exfoliants, cleansers, and dermal fillers. Advanced imaging techniques like multiphoton tomography have demonstrated the capacity of NPs (<100 nm) to penetrate the stratum corneum and accumulate in the viable epidermis. Biological studies indicate that internalized particles can induce oxidative stress, inflammatory cytokine release, and barrier disruption in keratinocytes. Environmental assessments reveal that aesthetic clinics contribute significantly to plastic waste burdens. However, sustainable alternatives and biodegradable microbeads show promising efficacy without the associated ecological or biological risks. Conclusions: The aesthetic medicine sector faces a critical pivot point regarding synthetic polymer use. While current evidence suggests potential dermatological risks particularly from nanometric particles, the industry is increasingly adopting sustainable innovations. Standardized regulatory frameworks and continued research into long-term systemic effects are essential for ensuring patient safety and environmental stewardship.